NIPT and Omega Genetik
This resource text is a comprehensive guide prepared by Omega Genetik Diagnosis and Evaluation Center, explaining the NIPT (Non-Invasive Prenatal Test) process for expectant mothers.
This podcast episode was prepared with AI assistance. The expressions in the content may occasionally have shortcomings or linguistic errors. The information here is for general informational purposes only; it does not constitute a diagnosis or treatment recommendation. For any evaluation and decision regarding your health condition, please consult your physician or Omega Genetik Diagnostic Evaluation Center.
About the Episode
This resource text is a comprehensive guide prepared by Omega Genetik Diagnosis and Evaluation Center, explaining the NIPT (Non-Invasive Prenatal Test) process for expectant mothers. The document explains how this screening test, performed in early pregnancy, detects potential genetic risks in the baby and that only a simple blood test is applied to the mother during the procedure. Different technological options such as VeriSeq, myPrenatal, and MomGuard are presented, emphasizing the reliability of Illumina NGS technology that underlies all these methods. Additionally, it is noted that the test is a screening tool rather than a diagnostic one, and the paths to follow in high-risk situations and the importance of expert support are emphasized. Operational details such as Omega's home healthcare service and international laboratory processes are also included in the informational scope. Ultimately, this resource summarizes complex scientific data in a simple and reassuring language for families to make informed decisions.